| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Jian Huang, Xiao Fan, Xueqin Jin, Sooyeon Jo, Hanxiong Bear Zhang, Akie Fujita, Bruce P Bean, Nieng Ya. Cannabidiol inhibits Na Nature communications. vol 14. issue 1. 2023-06-17. PMID:37330538. |
cannabidiol inhibits na cannabidiol (cbd), a major non-psychoactive phytocannabinoid in cannabis, is an effective treatment for some forms of epilepsy and pain. |
2023-06-17 |
2023-08-14 |
Not clear |
| Tom Jukier, Crisanta Cruz-Espindola, Doug Martin, Dawn M Booth. Disposition of a single oral dose of a cannabidiol medication in healthy cats. Frontiers in veterinary science. vol 10. 2023-06-12. PMID:37303724. |
recently, the food and drug administration has approved a highly purified cannabidiol medication for the add on therapy in people with certain forms of epilepsy. |
2023-06-12 |
2023-08-14 |
Not clear |
| Caroline Esmonde-White, Richard S McLachlan, Jorge Burneo, Jayme Arts, Carmela Redhead, Ana Suller Mart. Nationwide Study of Postlegalization Marijuana Use Among Patients With Epilepsy in Canada. Neurology. Clinical practice. vol 13. issue 4. 2023-05-30. PMID:37251367. |
it was established before the legalization of marijuana in canada in 2018 that many patients with epilepsy use marijuana to treat their seizures or for recreational purposes. |
2023-05-30 |
2023-08-14 |
Not clear |
| Robert J Flamini, Anne M Comi, E Martina Bebin, Michael G Chez, Gary Clark, Orrin Devinsky, Shaun A Hussain, Paul D Lyons, Anup D Patel, Jillian L Rosengard, Farhad Sahebkar, Eric Segal, Laurie Seltzer, Jerzy P Szaflarski, Arie Weinstoc. Efficacy of cannabidiol in convulsive and nonconvulsive seizure types associated with treatment-resistant epilepsies in the expanded access program. Epilepsia. 2023-05-27. PMID:37243404. |
efficacy of cannabidiol in convulsive and nonconvulsive seizure types associated with treatment-resistant epilepsies in the expanded access program. |
2023-05-27 |
2023-08-14 |
Not clear |
| Robert J Flamini, Anne M Comi, E Martina Bebin, Michael G Chez, Gary Clark, Orrin Devinsky, Shaun A Hussain, Paul D Lyons, Anup D Patel, Jillian L Rosengard, Farhad Sahebkar, Eric Segal, Laurie Seltzer, Jerzy P Szaflarski, Arie Weinstoc. Efficacy of cannabidiol in convulsive and nonconvulsive seizure types associated with treatment-resistant epilepsies in the expanded access program. Epilepsia. 2023-05-27. PMID:37243404. |
cannabidiol (cbd) expanded access program (eap), initiated in 2014, provided cbd (epidiolex®) to patients with treatment-resistant epilepsy (tre). |
2023-05-27 |
2023-08-14 |
Not clear |
| Silvia Kochen, Manuela Villanueva, Liliana Bayarres, Anilu Daza-Restrepo, Silvia Gonzalez Martinez, Silvia Odd. Cannabidiol as an adjuvant treatment in adults with drug-resistant focal epilepsy. Epilepsy & behavior : E&B. vol 144. 2023-05-17. PMID:37196452. |
cannabidiol as an adjuvant treatment in adults with drug-resistant focal epilepsy. |
2023-05-17 |
2023-08-14 |
Not clear |
| Mark Tripson, Karen Litwa, Ken Soderstro. Cannabidiol inhibits neuroinflammatory responses and circuit-associated synaptic loss following damage to a songbird vocal pre-motor cortical-like region. Scientific reports. vol 13. issue 1. 2023-05-16. PMID:37193782. |
the non-euphorigenic phytocannabinoid cannabidiol (cbd) has been used successfully to treat childhood-onset epilepsies. |
2023-05-16 |
2023-08-14 |
Not clear |
| Daphna T Katz, Amanda Fifi, Alessandra Milesi-Halle, Miguel Sap. A Rare Case of Cannabinoid Hyperemesis Syndrome Secondary to Cannabidiol for Refractory Epilepsy. JPGN reports. vol 4. issue 1. 2023-05-15. PMID:37181918. |
a rare case of cannabinoid hyperemesis syndrome secondary to cannabidiol for refractory epilepsy. |
2023-05-15 |
2023-08-14 |
Not clear |
| Daphna T Katz, Amanda Fifi, Alessandra Milesi-Halle, Miguel Sap. A Rare Case of Cannabinoid Hyperemesis Syndrome Secondary to Cannabidiol for Refractory Epilepsy. JPGN reports. vol 4. issue 1. 2023-05-15. PMID:37181918. |
cannabidiol is used in treatment-refractory epilepsy. |
2023-05-15 |
2023-08-14 |
Not clear |
| Daphna T Katz, Amanda Fifi, Alessandra Milesi-Halle, Miguel Sap. A Rare Case of Cannabinoid Hyperemesis Syndrome Secondary to Cannabidiol for Refractory Epilepsy. JPGN reports. vol 4. issue 1. 2023-05-15. PMID:37181918. |
this is the first case of chs secondary to cannabidiol for refractory epilepsy reported in the literature. |
2023-05-15 |
2023-08-14 |
Not clear |
| Roberto H Caraballo, Gabriela Reyes Valenzuela, Sebastian Fortini, Alberto Espeche, Beatriz Gamboni, Walter Silva, Marco Semprino, Lorena Fasulo, Santiago Chacón, Adolfo Gallo, Santiago Galicchio, Pedro Cachi. Cannabidiol in children with treatment-resistant epilepsy with myoclonic-atonic seizures. Epilepsy & behavior : E&B. vol 143. 2023-05-14. PMID:37182500. |
cannabidiol in children with treatment-resistant epilepsy with myoclonic-atonic seizures. |
2023-05-14 |
2023-08-14 |
Not clear |
| Roberto H Caraballo, Gabriela Reyes Valenzuela, Sebastian Fortini, Alberto Espeche, Beatriz Gamboni, Walter Silva, Marco Semprino, Lorena Fasulo, Santiago Chacón, Adolfo Gallo, Santiago Galicchio, Pedro Cachi. Cannabidiol in children with treatment-resistant epilepsy with myoclonic-atonic seizures. Epilepsy & behavior : E&B. vol 143. 2023-05-14. PMID:37182500. |
this multicenter study aimed to evaluate the efficacy and tolerability of add-on cannabidiol (cbd) in treatment-resistant patients with epilepsy with myoclonic-atonic seizures (emats) (n = 22) and sturge weber syndrome (sws) with myoclonic-atonic seizures (n = 4). |
2023-05-14 |
2023-08-14 |
Not clear |
| Maitri Patel, Jeremy P Middleton, Howard P Goodkin, Barrett Barnes, Emily McGowan, Ryan Ei. Persistent Diarrhea and Eosinophilic Esophagitis Resulting From Chronic Cannabidiol Usage for Refractory Epilepsy. JPGN reports. vol 3. issue 4. 2023-05-11. PMID:37168471. |
persistent diarrhea and eosinophilic esophagitis resulting from chronic cannabidiol usage for refractory epilepsy. |
2023-05-11 |
2023-08-14 |
Not clear |
| Maitri Patel, Jeremy P Middleton, Howard P Goodkin, Barrett Barnes, Emily McGowan, Ryan Ei. Persistent Diarrhea and Eosinophilic Esophagitis Resulting From Chronic Cannabidiol Usage for Refractory Epilepsy. JPGN reports. vol 3. issue 4. 2023-05-11. PMID:37168471. |
cannabidiol is used in the care of treatment-resistant epilepsy. |
2023-05-11 |
2023-08-14 |
Not clear |
| Mauro Maccarrone, Vincenzo Di Marzo, Juerg Gertsch, Uwe Grether, Allyn C Howlett, Tian Hua, Alexandros Makriyannis, Daniele Piomelli, Natsuo Ueda, Mario van der Stel. Pharmacological reviews. 2023-05-10. PMID:37164640. |
compelling research evidence and the fda cannabis-derived cannabidiol approval for severe childhood epilepsy have confirmed the large therapeutic potential of cannabidiol itself, Δ9-tetrahydrocannabinol (thc) and other plant-derived cannabinoids (phytocannabinoids). |
2023-05-10 |
2023-08-14 |
human |
| Renad M Alsolamy, Talah Almaddah, Ammar Aljabri, Hadeel A Maaddawi, Faris Alzahrani, Maha Gashla. Knowledge and Attitude of Saudi Physicians Toward Cannabidiol for Pediatric Epilepsy: A Cross-Sectional Study. Cureus. vol 15. issue 3. 2023-05-09. PMID:37155439. |
knowledge and attitude of saudi physicians toward cannabidiol for pediatric epilepsy: a cross-sectional study. |
2023-05-09 |
2023-08-14 |
human |
| Renad M Alsolamy, Talah Almaddah, Ammar Aljabri, Hadeel A Maaddawi, Faris Alzahrani, Maha Gashla. Knowledge and Attitude of Saudi Physicians Toward Cannabidiol for Pediatric Epilepsy: A Cross-Sectional Study. Cureus. vol 15. issue 3. 2023-05-09. PMID:37155439. |
various institutions have shown an interest to investigate the role of cannabidiol (cbd) in treating pediatric epilepsy. |
2023-05-09 |
2023-08-14 |
human |
| Minahil Riaz, Amna Anwa. Letter to the Editor: Second-line cannabis therapy in patients with epilepsy. Clinical neurology and neurosurgery. vol 229. 2023-05-06. PMID:37148819. |
letter to the editor: second-line cannabis therapy in patients with epilepsy. |
2023-05-06 |
2023-08-14 |
Not clear |
| Asra Fazlollahi, Mahdi Zahmatyar, Mahta ZareDini, Behnam Golabi, Seyed Aria Nejadghaderi, Mark J M Sullman, Koroush Gharagozli, Ali-Asghar Kolahi, Saeid Safir. Adverse Events of Cannabidiol Use in Patients With Epilepsy: A Systematic Review and Meta-analysis. JAMA network open. vol 6. issue 4. 2023-04-20. PMID:37079302. |
adverse events of cannabidiol use in patients with epilepsy: a systematic review and meta-analysis. |
2023-04-20 |
2023-08-14 |
Not clear |
| Anna Fetta, Elisa Crotti, Elena Campostrini, Luca Bergonzini, Carlo Alberto Cesaroni, Francesca Conti, Veronica Di Pisa, Valentina Gentile, Maria Cristina Mondardini, Cesare Vezzoli, Lucio Giordano, Duccio Maria Cordell. Cannabidiol in the acute phase of Febrile Infection-Related Epilepsy Syndrome (FIRES). Epilepsia open. 2023-04-12. PMID:37042946. |
cannabidiol in the acute phase of febrile infection-related epilepsy syndrome (fires). |
2023-04-12 |
2023-08-14 |
Not clear |